OBJECTIVE： To explore the clinical efficacy and safety of oxymatrine membrane， rhEGF gel respectively combined with Yunnan baiyao for postoperative cervical wound after LEEP. METHODS： 300 patients with cervical intraepithelial neoplasia （CIN） Ⅱ and Ⅲ were divided into group A， B， C （100 cases in each group） based on CIN grading and stratification and random sampling in each stratification. After conventional LEEP， patients in group A were cleaned the wound by 0.9％ Sodium chloride injection， spraying Yunnan baiyao powder， once only after surgery； patients in group B were additionally given recombinant human epidermal growth factor （rhEGF） on the basis of group A， once every week after surgery， for 3 weeks； patients in group C were additionally given oxymatrine membrane on the basis of group A， 1 tablet every evening after surgery， for 2 weeks. Postoperative bleeding， bleeding duration， rebleeding and duration after postoperative bleeding stopped， postoperative drainage duration， the incidence of adverse reactions in 3 groups were observed. RESULTS： The patients of postoperative bleeding， bleeding time ≥7 d and rebleeding after stopping bleeding in group B were significantly lower than group A； the incidence of bleeding time ≥7 d in group C was significantly lower than group A， the proporition of postoperative drainage duration for less than 7 d was significantly higher than group A， for 8-13 d was significantly less than group A； early wound healing rate in group B and group C were significantly better than group A， with statistical significances （P＜0.05）. There were no significant differences in above-mentioned indexes in group B and group C （P＞0.05）， and there were no obvious adverse reactions in 3 groups. CONCLUSIONS： Oxymatrine membrane and rhEGF gel respectively combined with Yunnan baiyao have better healing than Yunnan baiyao alone， do not increase the incidence of adverse reactions， while there is no significant difference in oxymatrine membrane and rhEGF gel.